Profitelligence Profitelligence · Filing Ledger Open ZTS research →

Form 8-K · Current Report · Filed 2025-12-02

Zoetis Inc. to Host Innovation Webcast on December 2, 2025

On December 2, 2025, Zoetis Inc. announced it will host an Innovation Webcast at 8:30 a.m. ET, discussing the shaping of the next era in animal health, focusing on market opportunity, proven innovation model, robust pipeline, and driving value. A presentation for the webcast is attached as Exhibit 99.1.

Filer
Zoetis Inc. ZTS · NYSE
Filed
Accession
0001555280-25-000280
CIK
0001555280
Signal
Low impactHealthcare

Items reported

Item 8.01

Other Events

Corporate Update
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$127.25

Next session

-3.7%

Since filing

-39.3%

Latest close

$77.29

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from ZTS reporting the same item, with the next session's move:

About Zoetis Inc.

Zoetis Inc. is a global leader in the animal healthcare sector, specializing in the development, manufacture, and commercialization of a diverse range of medicines and vaccines for pets and livestock. Originally part of Pfizer, Zoetis spun off in 2013 and has solidified its position as a key player in the industry. The company's portfolio includes products aimed at veterinarians and livestock producers, supporting health and productivity across various animal species. Zoetis's impact is significant in both the companion animal market, which is driven by increasing pet ownership and rising expenditure on pet care, and the livestock market, which benefits from enhancements in productivity and disease management. Zoetis operates in over 100 countries, continuously investing in research and innovation to address the evolving needs of animal health. Its strategic initiatives and partnerships contribute to building a sustainable future for the animal health industry, bolstering Zoetis’s reputation and relevance in the global market.

Exchange NYSE Industry Drug Manufacturers - Specialty & Generic Company website ↗

Never miss another ZTS filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts